Annual Cash & Cash Equivalents
$39.23 M
+$8.00 M+25.62%
31 December 2023
Summary:
Tempest Therapeutics annual cash & cash equivalents is currently $39.23 million, with the most recent change of +$8.00 million (+25.62%) on 31 December 2023. During the last 3 years, it has risen by +$20.41 million (+108.45%). TPST annual cash & cash equivalents is now -24.31% below its all-time high of $51.83 million, reached on 31 December 2021.TPST Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$22.12 M
-$9.01 M-28.94%
30 September 2024
Summary:
Tempest Therapeutics quarterly cash and cash equivalents is currently $22.12 million, with the most recent change of -$9.01 million (-28.94%) on 30 September 2024. Over the past year, it has increased by +$11.00 million (+98.92%). TPST quarterly cash and cash equivalents is now -67.67% below its all-time high of $68.41 million, reached on 30 June 2021.TPST Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TPST Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.6% | +98.9% |
| 3 y3 years | +108.5% | -63.0% |
| 5 y5 years | - | - |
TPST Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -24.3% | +108.5% | -63.0% | +98.9% |
| 5 y | 5 years | -24.3% | +108.5% | -67.7% | +98.9% |
| alltime | all time | -24.3% | +108.5% | -67.7% | +98.9% |
Tempest Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $22.12 M(-28.9%) |
| June 2024 | - | $31.12 M(-3.7%) |
| Mar 2024 | - | $32.33 M(-17.6%) |
| Dec 2023 | $39.23 M(+25.6%) | $39.23 M(+252.9%) |
| Sept 2023 | - | $11.12 M(-36.8%) |
| June 2023 | - | $17.60 M(-23.2%) |
| Mar 2023 | - | $22.93 M(-26.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $31.23 M(-39.7%) | $31.23 M(-27.0%) |
| Sept 2022 | - | $42.79 M(-17.1%) |
| June 2022 | - | $51.62 M(+12.8%) |
| Mar 2022 | - | $45.75 M(-11.7%) |
| Dec 2021 | $51.83 M(+175.4%) | $51.83 M(-13.2%) |
| Sept 2021 | - | $59.72 M(-12.7%) |
| June 2021 | - | $68.41 M(+263.5%) |
| Dec 2020 | $18.82 M | $18.82 M |
FAQ
- What is Tempest Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Tempest Therapeutics?
- What is Tempest Therapeutics annual cash & cash equivalents year-on-year change?
- What is Tempest Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Tempest Therapeutics?
- What is Tempest Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Tempest Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of TPST is $39.23 M
What is the all time high annual cash & cash equivalents for Tempest Therapeutics?
Tempest Therapeutics all-time high annual cash & cash equivalents is $51.83 M
What is Tempest Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, TPST annual cash & cash equivalents has changed by +$8.00 M (+25.62%)
What is Tempest Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TPST is $22.12 M
What is the all time high quarterly cash and cash equivalents for Tempest Therapeutics?
Tempest Therapeutics all-time high quarterly cash and cash equivalents is $68.41 M
What is Tempest Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, TPST quarterly cash and cash equivalents has changed by +$11.00 M (+98.92%)